TFFP
Income statement / Annual
Last year (2023), TFF Pharmaceuticals, Inc.'s total revenue was $733,871.00,
and the percentage change from the previous year is not available.
In 2023, TFF Pharmaceuticals, Inc.'s net income was -$21.24 M.
See TFF Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$733,871.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$502,480.00 |
$388,221.00 |
$111,453.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$231,391.00 |
-$388,221.00 |
-$111,453.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0.32 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$11.56 M
|
$18.50 M
|
$21.30 M
|
$10.68 M
|
$8.82 M
|
$848,809.00
|
$0.00
|
$229,259.00
|
| General & Administrative
Expenses |
$10.57 M
|
$13.80 M
|
$10.57 M
|
$8.01 M
|
$3.17 M
|
$0.00
|
$178,605.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$10.57 M
|
$13.80 M
|
$10.57 M
|
$8.01 M
|
$3.17 M
|
$3.05 M
|
$178,605.00
|
$141,111.00
|
| Other Expenses |
$0.00 |
-$495,805.00 |
-$88,161.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$22.63 M |
$31.80 M |
$31.79 M |
$18.69 M |
$11.99 M |
$3.90 M |
$178,605.00 |
$370,370.00 |
| Cost And Expenses |
$22.63 M |
$31.80 M |
$31.79 M |
$18.69 M |
$11.99 M |
$3.90 M |
$178,605.00 |
$370,370.00 |
| Interest Income |
$0.00 |
$26,728.00 |
$51,232.00 |
$126,416.00 |
$117,329.00 |
$55,960.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$502,480.00
|
$388,221.00
|
$111,453.00
|
$206,297.00
|
$171,860.00
|
$0.00
|
$52,516.00
|
$0.00
|
| EBITDA |
-$20.74 M
|
-$31.41 M
|
-$30.93 M
|
-$18.69 M
|
-$11.99 M
|
-$3.90 M
|
-$178,605.00
|
-$370,370.00
|
| EBITDA Ratio |
-28.26 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-29.83
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$651,431.00
|
$26,728.00
|
$747,946.00
|
$126,416.00
|
$117,329.00
|
$55,964.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$21.24 M |
-$31.77 M |
-$31.04 M |
-$18.57 M |
-$11.87 M |
-$3.84 M |
-$178,605.00 |
-$370,370.00 |
| Income Before Tax Ratio
|
-28.95
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$26.73 |
-$51,232.00 |
-$126,416.00 |
-$117,329.00 |
$0.00 |
-$52,521.00 |
$0.00 |
| Net Income |
-$21.24 M |
-$31.77 M |
-$30.99 M |
-$18.44 M |
-$11.75 M |
-$3.84 M |
-$178,605.00 |
-$370,370.00 |
| Net Income Ratio |
-28.95 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-11.85 |
-26.49 |
-31.21 |
-22.57 |
-42.55 |
-5.21 |
-0.01 |
-0.5 |
| EPS Diluted |
-11.85 |
-26.49 |
-31.21 |
-22.57 |
-42.55 |
-5.21 |
-0.01 |
-0.5 |
| Weighted Average Shares
Out |
$1.79 M
|
$1.20 M
|
$992,838.00
|
$817,006.00
|
$276,199.00
|
$738,039.00
|
$17.83 M
|
$738,039.00
|
| Weighted Average Shares
Out Diluted |
$1.79 M
|
$1.20 M
|
$992,838.00
|
$817,006.00
|
$276,199.00
|
$738,039.00
|
$17.83 M
|
$738,039.00
|
| Link |
|
|
|
|
|
|
|
|
